British pharmaceutical firm Indivior Inc. was indicted Tuesday over an alleged scheme to push its treatment for opioid addicts and reap billions of dollars from it.
Apr 10, 2019
0
1
A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.
Dec 16, 2016
0
0
The federal jury in a patent trial has ordered drugmaker Gilead Sciences to pay Merck $200 million in damages for infringing on patents for hepatitis C drugs.
Mar 25, 2016
0
0
A federal jury in California has ruled in favor of drugmaker Merck & Co. in a high-stakes lawsuit against rival Gilead Sciences Inc. over patents for lucrative new drugs that rapidly cure hepatitis C.
Mar 22, 2016
0
2
A federal jury has rejected claims by a group of Massachusetts smokers who sued Philip Morris USA to try to force the cigarette maker to pay for lung cancer screenings.
Feb 11, 2016
0
0
Japan's top drugmaker Takeda Pharmaceutical has offered $2.2 billion to settle US claims linked to its diabetes drug Actos, in what would be one of the biggest US payouts over patient lawsuits, a report said Wednesday.
Apr 1, 2015
0
12
